Overview
- Editors:
-
-
Ronald W. Ellis
-
Vaccine Development, BioChem Pharma, Inc., Northborough, USA
Access this book
Other ways to access
Table of contents (12 chapters)
-
-
- Emmanuel Vidor, Agnes Hoffenbach, Stanley Plotkin
Pages 1-33
-
-
- Dennis M. Katkocin, Chia-Lung Hsieh
Pages 51-93
-
- Peter R. Paradiso, Robert Kohberger
Pages 95-106
-
-
-
- Kenneth R. Brown, Francis M. Ricci
Pages 155-169
-
- Paul A. Offit, H. Fred Clark
Pages 171-195
-
-
-
- Lydia A. Falk, Karen Midthun, Loris D. McVittie, Karen L. Goldenthal
Pages 233-248
-
- Kathryn M. Edwards, Michael D. Decker
Pages 249-267
-
Back Matter
Pages 269-279
About this book
A diverse team of leading experts comprehensively review the complex biology of a wide variety of vaccine combinations, as well as the technical, clinical, and regulatory aspects of their development. Topics covered range from the use of immunological correlates of efficacy, rather than efficacy per se, for the evaluation and licensure of vaccine combinations, to preserving a stable immunogenic mixture in appropriate containers according to accepted regulatory standards. Discussed in detail are the trivalent influenza vaccine, the pneumococcal polysaccharide vaccine, the MMR vaccine, the DTP vaccine and its combinations, and the quadrivalent rotavirus vaccine, all of which serve as models for the development of future combinations. Combination Vaccines: Development, Clinical Research, and Approval illuminates all the scientific, clinical, regulatory, and health care issues involved in the research, development, and human use of combination vaccines.
Editors and Affiliations
-
Vaccine Development, BioChem Pharma, Inc., Northborough, USA
Ronald W. Ellis
